Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 3-DIMENSIONAL PHARMACEUTICALS (DDDP) -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (58)	2/14/2002 9:05:06 PM
From: mopgcw	Read Replies (1) \| Respond to of 146

3-Dimensional Pharmaceuticals Announces Webcast of Presentation At BIO CEO & Investor Conference YARDLEY, Pa., Feb. 14 /PRNewswire-FirstCall/ -- 3-Dimensional Pharmaceuticals, Inc. (Nasdaq: DDDP - news) today announced that David C. U'Prichard, Ph.D., Chief Executive Officer, will present at the Fourth Annual BIO CEO & Investor Conference at 10:30 a.m. ET on Friday, February 22, 2002. 3DP's presentation will be webcast live by CCBN and archived for 30 days after the conference. For access to the webcast, please visit the ``Investor Relations'' page at: www.3dp.com and click on the ``Events Calendar'' link. About the company 3DP (http://www.3dp.com) is an integrated bio-pharmaceuticals company dedicated to revolutionizing small molecule drug discovery and development. 3DP's proprietary platform, DiscoverWorks®, can be applied to virtually any potential drug target. It produces drug candidates suitable for faster development, with fewer resources and a higher probability of success than using conventional drug discovery methods. 3DP is developing its own drug pipeline and collaborates with other pharmaceutical companies in discovery and development.